Span-America Expects to Receive Insurance Proceeds Following Death of Company Founder and Former CEO, Donald C. Spann
February 02 2017 - 4:30PM
Business Wire
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced
today that the company’s founder and former Chief Executive
Officer, Donald C. Spann, passed away on January 6, 2017. He was
age 82. As previously reported, the company has had retirement and
resignation agreements in place since 1993 when Mr. Spann retired
from the company. These agreements provided for payments of
$113,561 per year to Mr. Spann and his former wife. Mr. Spann’s
former wife survives him, so in accordance with these agreements,
the company will continue to make the retirement payments to Ms.
Spann for the remainder of her life.
To help fund the company’s payment obligations under the
retirement arrangement, the company owns and is the beneficiary of
three life insurance policies on Mr. Spann that were put in place
from 1981 through 1993. These policies had a total death benefit of
approximately $3.3 million and a total cash value of approximately
$2.6 million as of December 31, 2016. The cash value of these
policies has been recorded in “Other assets” on the Company’s
balance sheet. As of December 31, 2016, the company had recognized
a liability of approximately $380,000, which represents the present
value of the expected future retirement payments to be made to Ms.
Spann. This liability has been recorded in “Accrued and sundry
liabilities” and “Deferred compensation” on the company’s balance
sheet.
As a result of Mr. Spann’s death, the company expects to receive
the life insurance proceeds of approximately $3.3 million in cash.
We will remove from the company’s balance sheet the associated cash
value of the life insurance policies of approximately $2.6 million.
The difference between the total life insurance proceeds and the
total cash values of the policies is approximately $700,000 and
will be recorded as non-operating income in the second quarter of
fiscal 2017. The resulting effect on the company’s financial
statements from these transactions will be as follows:
- “Cash and cash equivalents” on the
balance sheet will increase by approximately $3.3 million.
- “Other assets” on the balance sheet
will decrease by approximately $2.6 million, which is the cash
value of the life insurance policies prior to Mr. Spann’s
death.
- “Non-operating income” on the income
statement will increase by approximately $700,000.
For more information, see Notes 2, 7 and 11 in the Notes to
Consolidated Financial Statements and “Critical Accounting Policies
– Present Value of Deferred Compensation” in Management’s
Discussion and Analysis of Financial Condition and Results of
Operations in the Company’s annual report on Form 10-K for the
fiscal year ended October 1, 2016.
Forward-Looking Statements
We have made forward-looking statements in this release
regarding our expectations for changes to the Company’s financial
statements as a result of the death of the Company’s founder and
former CEO. We wish to caution the reader that these statements
involve estimates of life insurance proceeds, cash values and
income. These amounts are based on data available to the Company as
of December 31, 2016, and are subject to change between the current
value date of December 31, 2016, and the date the life insurance
proceeds are actually received. The differences between the
estimated values and the actual values could be caused by changes
in the market values of the underlying investments in the life
insurance policies, which could change the amount of life insurance
proceeds received and the cash values of the policies. We are not
responsible for changes made to this document by wire services or
Internet services.
About Span-America Medical Systems, Inc.
Span-America manufactures and markets a comprehensive selection
of pressure management products for the medical market, including
Geo-Matt®, PressureGuard®, Geo-Mattress®, Custom Care®, Span+Aids®,
Isch-Dish®, Risk Manager® and Selan® products. Through our
wholly-owned subsidiary Span Medical Products Canada Inc., we
manufacture and market the Encore®, Advantage and Rexx beds as
well as related in-room furnishing products for the long-term care
market. We also supply custom foam and packaging products to the
consumer and industrial markets. Span-America’s stock
is traded on The NASDAQ Global Market under the
symbol “SPAN.” For more information, please visit
www.spanamerica.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170202006238/en/
Span-America Medical Systems, Inc.Jim Ferguson, 864-288-8877,
ext. 6912President and Chief Executive Officer
Span America (NASDAQ:SPAN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Span America (NASDAQ:SPAN)
Historical Stock Chart
From Nov 2023 to Nov 2024